Health-Related Quality of Life and Psychological States in Patients With Pulmonary Arterial Hypertension

被引:51
作者
Matura, Lea Ann [1 ]
McDonough, Annette [2 ]
Carroll, Diane L. [3 ]
机构
[1] Univ Penn, Sch Nursing, Dept Biobehav Hlth Sci, Philadelphia, PA 19104 USA
[2] Univ Massachusetts, Dept Nursing, Lowell, MA USA
[3] Massachusetts Gen Hosp, Inst Patient Care, Yvonne L Munn Ctr Nursing Res, Boston, MA 02114 USA
关键词
affect; health-related quality of life; pulmonary arterial hypertension; CONGESTIVE-HEART-FAILURE; REPORTED OUTCOMES; VALIDATION; QUESTIONNAIRE; EXPERIENCE; DISABILITY; SYMPTOMS;
D O I
10.1097/JCN.0b013e318275330d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary arterial hypertension (PAH) is a chronic illness that impairs physical function and leads to right-sided heart failure and premature death. There is limited knowledge on health-related quality of life (HRQOL) and psychological states in patients with PAH. Objective: The aim of this study was to determine the HRQOL and the psychological states of patients with PAH along with predictors of HRQOL. Methods: In a cross-sectional design, participants with PAH completed the Medical Outcomes Study Short Form-36 v2 to measure generic HRQOL, the US Cambridge Pulmonary Hypertension Outcome Review to measure disease-specific HRQOL, and the Profile of Mood States to measure the psychological states. Descriptive statistics were used to calculate all sociodemographic and clinical data and were expressed as means and standard deviations for continuous variables and as frequencies and proportions for dichotomous and nominal variables. The statistical significance level was set at P < 0.05. A multiple linear regression analysis was performed to examine the sociodemographic and clinical variables as predictors of HRQOL. A bivariate analysis of the sociodemographic and clinical variables was performed to determine correlates with HRQOL. The variables that correlated with HRQOL at the 0.20 level of significance were included. Results: There were 149 participants, 127 women and 22 men, with a mean age of 53.5 years. The participants demonstrated diminished general health, physical functioning, role physical, and vitality on the Short Form-36 v2. Functional class, education level, oxygen use, years since diagnosis, and calcium channel blocker therapy were predictive of poorer HRQOL. Conclusions: Patients with PAH are experiencing diminished physical health and HRQOL. Future studies are needed to design and test interventions to improve HRQOL.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 50 条
  • [21] Sexual Health-related Quality of Life in Women with Pulmonary Arterial Hypertension Compensating for Loss
    Yee, Daniel C.
    Banerjee, Debasree
    Vargas, Sara E.
    Allahua, Melissa
    Whittenhall, Mary E.
    Perry, Nicholas
    Ventetuolo, Corey E.
    Guthrie, Kate M.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (07) : 1122 - 1129
  • [22] Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension
    Wong, Raymond Ching-Chiew
    Koh, Geok Mui
    Choong, Poh Hoon
    Yip, Wei Luen James
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 119 (03) : 400 - 402
  • [23] The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension
    S. P. McKenna
    N. Doughty
    D. M. Meads
    L. C. Doward
    J. Pepke-Zaba
    Quality of Life Research, 2006, 15 : 103 - 115
  • [24] Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study
    Sood, Namita
    Aranda, Alvaro
    Platt, David
    LaRose, Anneliese
    Kleinjung, Frank
    O'Brien, Gerald
    PULMONARY CIRCULATION, 2019, 9 (01)
  • [25] Factors of impaired health-related quality of life in patients with precapillary pulmonary hypertension
    Stefanidou, Aristoula
    Kosmidis, Diamantis
    Arvanitaki, Alexandra
    Panagiotidou, Evangelia
    Mouratoglou, Sofia-Anastasia
    Boutou, Afroditi
    Giannakoulas, George
    Karvounis, Haralambos
    Ziakas, Antonios
    Stanopoulos, Ioannis
    Pitsiou, Georgia
    PNEUMON, 2024,
  • [26] The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A measure of health-related quality of life and quality of life for patients with pulmonary hypertension
    McKenna, S
    Doughty, N
    Meads, D
    Doward, L
    Pepke-Zaba, J
    QUALITY OF LIFE RESEARCH, 2006, 15 (01) : 103 - 115
  • [27] EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR
    Borgese, Marissa
    Badesch, David
    Bull, Todd
    Chakinala, Murali
    DeMarco, Teresa
    Feldman, Jeremy
    Ford, H. James
    Grinnan, Dan
    Klinger, James R.
    Bolivar, Lena
    Shlobin, Oksana A.
    Frantz, Robert P.
    Sager, Jeffery S.
    Mathai, Stephen C.
    Kawut, Steven
    Leary, Peter J.
    Gray, Michael P.
    Popat, Rita A.
    Zamanian, Roham T.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [28] Clinical and psychological correlates of health-related quality of life in obese patients
    Mannucci, Edoardo
    Petroni, Maria L.
    Villanova, Nicola
    Rotella, Carlo M.
    Apolone, Giovanni
    Marchesini, Giulio
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2010, 8
  • [29] Health-Related Quality of Life Among Patients With Peripheral Arterial Disease
    Maksimovic, Milos
    Vlajinac, Hristina
    Marinkovic, Jelena
    Kocev, Nikola
    Voskresenski, Tatjana
    Radak, Djordje
    ANGIOLOGY, 2014, 65 (06) : 501 - 506
  • [30] Association of risk assessment at diagnosis with healthcare resource utilization and health-related quality of life outcomes in pulmonary arterial hypertension
    Lawrie, Allan
    Hamilton, Neil
    Wood, Steven
    Exposto, Fernando
    Muzwidzwa, Ruvimbo
    Raiteri, Louise
    Beaudet, Amelie
    Muller, Audrey
    Sauter, Rafael
    Pillai, Nadia
    Kiely, David G.
    PULMONARY CIRCULATION, 2024, 14 (03)